Abstract
Reinitiation of clozapine was found to be among the safest and most effective treatment options for patients with schizophrenia who had discontinued use of clozapine, according to a national registry study. The results contradicted researchers' hypothesis that former users of clozapine should avoid resuming use based on limited efficacy or lack of tolerability. Results were published online Jan. 8 in The British Journal of Psychiatry.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
